‘We should have followed up’: Lancet journal retracts article on hearing aids and dementia after prodding

via pxhere

When Jure Mur, a postdoc at the University of Edinburgh in Scotland, realized the replication of a published study he was working on as a “sanity check” wasn’t producing matching results, his first reaction was “annoyance,” he said. 

He assumed the mistake was his own, and he’d have to thoroughly check his work to find it. “Only after double- and triple-checking my code did I start suspecting an error in the original paper,” Mur told Retraction Watch. 

Mur emailed the authors of the article several times, but they never responded to him, he said. He next contacted the editors of The Lancet Public Health, which had published the original paper, “Association between hearing aid use and all-cause and cause-specific dementia: an analysis of the UK Biobank cohort,” in April 2023. 

In months of back-and-forth correspondence, seen by Retraction Watch, Mur explained the discrepancies he’d found, then submitted a comment article the editors declined to publish. 

The paper was retracted in December, but only after Mur pushed the editors to consider the implications of the authors’ response to his comment, which confirmed his findings and contradicted their original paper. 

“The end result is positive for the scientific community,” Mur said. But because the editors seemed to address the issue he raised only after he and his colleagues submitted a comment article, and “either did not read or did not understand the response to our comment,” he said the experience “made me doubt the integrity of the editorial process at the journal.” 

Given the high praise the article received when it was first published, the analysis should be corrected and republished, not just retracted, said Jan Blustein, a professor at New York University who studies hearing loss.  

“It was declared to be the final word, and it’s apparently not,” she said. 

The Lancet Public Health article made international headlines when it appeared, from Der Spiegel to CNN (also in Spanish) to The Daily Mail. (CNN has added an update about the retraction to their story and removed references to the study.) It has been cited 15 times, according to Clarivate’s Web of Science. 

“In people with hearing loss,” the authors wrote, “hearing aid use is associated with a risk of dementia of a similar level to that of people without hearing loss.” They proposed “up to 8% of dementia cases could be prevented with proper hearing loss management.”

In a simultaneously published editorial–now also retracted–other researchers wrote that with the addition of the article’s data, “the evidence that hearing aids can be a powerful tool to reduce the risk of dementia in people with hearing loss is as good as possible without randomised controlled trials.”  

Mur and his colleagues intended to build on the article with a related analysis on the same UK Biobank data. But when he couldn’t replicate the main findings, Mur scrutinized the paper more deeply. 

In mid-May, Mur emailed the corresponding author, Dongshan Zhu of Shandong University in Jinan, China. He wrote that he “had some questions regarding your analysis” and asked whether he should direct them to Zhu or the first author of the paper. Mur followed up several times, but Zhu never responded, he said. 

Mur also emailed the editors of The Lancet Public Health in late May, asking if they would share any other authors’ email addresses they had. He explained that he’d been having trouble replicating some of the findings in the paper, and the corresponding author hadn’t responded to his emails. One of the editors supplied the email address for another author, Chengchao Zhou, also affiliated with Shandong University. Mur’s emails to Zhou went unanswered as well. 

At the editors’ suggestion, Mur sent another email to Zhu and Zhou in June asking if they would share their code, and copied the editors. After again getting no response, Mur sent the editors a document detailing the discrepancies between his replication attempt and the results in the paper. 

Most notably, he found that hearing aid use did not correspond to a lower rate of dementia for people with hearing loss, as the authors reported. He found the opposite: among people with hearing loss, the dementia rate was higher for those using hearing aids. In his email to the editors, Mur wrote: 

Without comparing the code to clean and analyse the data, it is difficult to draw firm conclusions about what is going on. But I think it’s worth trying to resolve it.

In July, Audrey Ceschia, editor in chief of The Lancet Public Health, responded. She wrote that the journal had been “notified of an error in the paper” and was currently working with the authors on a correction that “might also help resolving some of the discrepancies you’ve noticed.” She said she would share the correction when it was ready, and also suggested Mur could submit his findings to the journal’s correspondence section. 

Mur and a few colleagues submitted a comment article to the journal in October, formally explaining the differences in their findings and the published paper, with a link to a repository of their code. In mid-November Ceschia sent Mur the authors’ response (with code they provided), but wrote that the journal had “decided not to publish the exchange of letters.” 

The authors’ response noted they had “found some discrepancies between coding schemes” and described a new analysis they’d run on the data. They reported on “the relationship between self-reported hearing loss, hearing aid use and risk of dementia,” as they had in their original paper, as well as an additional analysis on people who had severe hearing loss as measured with a hearing test. 

In supplementary material, the authors presented results in line with what Mur and his colleagues found, but contradicting their originally published work: 

Using self-reported hearing loss (no severity information), we found that in people with hearing loss, both using and not using [hearing aids] was linked to an increased risk of all-cause dementia, with HR (95% CI) of (1.47, 1.33-1.63) and (1.17, 1.09-1.25) respectively, i.e., using [hearing aids] had even higher risk of dementia

Mur responded to the journal editors, pointing out that this result “is exactly what we found, reported, and submitted as a comment to the Lancet Public Health and is contrary to the findings published by Jiang et al. (2023). Only in some of the supplementary analyses that were not part of that original published paper, do the authors find a confirmation of their original claim.” 

He continued: 

In my understanding of scientific integrity, it should now be the authors to retract the article based on these new analyses, or at least publish a major correction which includes a reinterpretation of findings in light of the extended analyses. Since they apparently do not intend to do so, we would now expect the publisher to take action and at least publish our comment (if you don’t plan on retracting the paper either). Please also note that the manuscript is a comment, not a correspondence piece. You may recall that we tried to have a correspondence with the authors and only decided to write a comment after multiple attempts were not successful..

The next day, Anika Knuppel, senior editor at the journal, responded that the editors were “looking into this.” A few weeks later, in early December, Ceschia wrote: 

Please accept our profound thanks for prompting us to investigate the reliability of the paper by Fan Jiang et al. To summarise an extensive series of exchanges with the authors, they have now explained that they have discovered analytical errors in their work that render their findings and conclusions false and misleading. We have taken the decision to retract their paper and will publish the retraction notice next week. We are very grateful to you for bringing your concerns to us directly and we are pleased to be able to correct the scientific record in a timely manner.

On December 12, The Lancet Public Health editors published the following retraction notice

On Nov 27, 2023, we have been informed by the authors of the paper—Association between hearing aid use and all-cause and cause-specific dementia: an analysis of the UK Biobank cohort—published on April 13, 2023,1 that an error was introduced in the output format setting of their SAS codes (data for people with hearing loss using hearing aids and with hearing loss without using hearing aids were switched), leading to errors in their analysis which render their findings and conclusions false and misleading. These errors were identified by the authors following an exchange with scientists seeking to reproduce the authors’ findings. We are therefore retracting this Article.

We asked Zhu why he and his colleagues had not requested a retraction once their reanalysis found different results than their original paper. He responded: 

Thanks for your attention to our research.

If the output formats were not mis-defined, using self-reported hearing loss, people with hearing loss using HA had 34% higher risk of dementia, and people with hearing loss not using HA had 7% higher risk dementia [sic].

We believe there are two prominent bias [sic] when self-reported hearing loss was used, i.e., self-reported bias, and hearing loss severity bias.

In the next step, we will try to control for self-report bias and severity bias to see the effect of wearing hearing aids after bias control on reducing the risk of dementia, especially in people with severe hearing loss.

When we reached out to Ceschia and Knuppel, we heard back from a spokesperson for The Lancet. Regarding the authors’ response to Mur and colleagues’ comment, the spokesperson said: 

While acknowledging “some discrepancies between coding systems”, they argued that “The overall message of the study did not change.” In good faith, we accepted the authors’ explanation, and decided not to publish the exchange. In retrospect, we should have followed up the admitted discrepancies more assiduously and worked with the authors and Dr Mur to settle any outstanding uncertainties. Dr Mur rightly challenged our decision in an email on November 16. We immediately recognised the seriousness of his concerns and wrote again to the authors on November 22 asking them to further clarify their analyses, based on Dr Mur’s evidence and our own by now heightened unease. On November 24, the authors reported major errors in their paper, which rendered their findings and conclusions false and misleading. We moved quickly to retract the paper on December 12, 2023.

When the paper first appeared, it seemed to confirm a widely held belief – that hearing loss is associated with developing dementia, and using hearing aids can help to reduce risk – about which the scientific evidence has been mixed, Blustein, the hearing loss researcher, told Retraction Watch. In her view, public health messaging and media coverage of the question has been “misleading.” 

The findings were picked up quickly and disseminated among the community of people following the question of hearing loss and dementia, she said. “I don’t think people are necessarily aware of retractions.” 

The analysis should be corrected, and if The Lancet Public Health were to receive a new version, they should publish it, Blustein said. 

The UK Biobank dataset “is a very valuable data source,” she said. The dataset’s large size, long followup period, and information about potentially confounding factors made the article an important piece of evidence. “To throw away data because somebody miscoded it is a mistake.”

Blustein also felt that the retraction notice was unclear about what readers should take away from the study, and the lack of clarity was “another reason why the record is incomplete” without a replacement analysis. 

While the retraction notice was “technically correct,” Mur said, it did “obfuscate the fact that it was primarily my colleagues and I – not the journal or the authors of the original paper – who identified a problem and invested plenty of time and effort to have it rectified.” 

To other researchers trying to correct the record, he advised: 

Be prepared for an uphill battle. In our case, the editors were always courteous and quick to respond to our emails but notifying them of the discrepancies and detailing them in a short report was not sufficient. We still had to write and submit a paper before any substantial action by the journal was evident.

But putting forth the effort was important, he said, “simply because we knew the results were erroneous.” He continued: 

The study had been mentioned in several media articles, featured in an editorial by the journal, and hailed by some in the field as the most definitive evidence on the topic one can get without performing a clinical trial. You can’t let that stand if you know it to be false.

Like Retraction Watch? You can make a tax-deductible contribution to support our work, subscribe to our free daily digest or paid weekly update, follow us on Twitter, like us on Facebook, or add us to your RSS reader. If you find a retraction that’s not in The Retraction Watch Database, you can let us know here. For comments or feedback, email us at [email protected].

14 thoughts on “‘We should have followed up’: Lancet journal retracts article on hearing aids and dementia after prodding”

  1. “In good faith, we accepted the authors’ explanation.”
    Ok, I know I’m a cynic, but journals need to get over this 1980s attitude. So much fraud and so many errors could be stopped from being published if the journals just changed their attitude from “trust, but verify” to “verify, then trust.

    1. Whatever the general logic, given the lack of replies to Mur even when the editors were on CC, it is clear that there was lack of good faith in this case.

  2. It is an offence in the UK and EU for selling a product without giving purchasers information that might change their minds about buying. Great Britain. (2008). The Consumer Protection from Unfair Trading Regulations. London: The Stationery Office. Would researchers have refrained from buying copies of this paper if they knew the facts? Arguably the law requires instant expression of concern.

    Under the normal understanding of plagiarism it would appear to be unethical to use information submitted by a whistleblower without giving them credit.

    It would normally be considered unethical for a reviewer or editor to take information from a submitted paper including a comment, and to use it for another paper, or to communicate it to someone else to use for their own purpose,especially if they then refused to print the submitted paper.

    It may be a breach of copyright to reveal the critic’s comment to the offender before publication though this could vary with the situation.

    1. Great idea to put this in the consumer protection realm. Anyone who actually bought the paper or paid for a subscription should have standing.
      More generally and as Mur found, correcting the record is an uphill battle. A consequence of journal editors often prioritizing journal prestige over science. A similar choice of prestige over science also is often made at the academic institution level. This is reflected in an actual comment made by a non-author faculty member during the early stage of an assessment of published anomalous data: “Why don’t we just see if anyone notices?”. In the end, the author was sanctioned for apparent fabrication but only after the typical uphill battle. The particular case also illustrates the lack of severe or long-term consequence for misconduct: the author’s position and prestige remains unaffected.

    1. COPE guidelines recommend that editors include in both correction and retraction notices some statement acknowledging the names of person(s) who brought the concerns to their attention, which might be the original authors, their employers, or others.
      While the anonymous acknowledgement in this retraction notice is better than nothing, it is clearly short of what COPE expects.
      I also wonder why the notice says the journal was informed of the coding error on November 27, 2023, when the Lancet spokesperson later said the authors reported this on November 24.

  3. So the person who did the work and wrote the paper to describe it was REJECTED a publication of the work even though everyone agreed that he was right. He and his team has not even given credit anywhere officially in the end result. This is in itself as unethical as it gets. He should have been allowed to publish his paper and get credit. AND the original paper should have been retracted. Now we have a case of plagiarism where the changed paper is changed entirely based on his contribution but he is not a co-author on it. I almost can’t believe his civilized comments, I would have been livid. (All the more so because he’s a postdoc and at this stage every paper counts.)

  4. Two things of note on Lancet’s behavior: First, if an article was worth publishing (and promoting) in the first place, why are the scholarly comments not worth publishing. Second, how hard is it to include contact information for all authors, instead of just the senior, corresponding author? Senior authors seldom bother to respond when as an AE I’m looking for reviewers, and often seem disengaged from the paper. It’s particularly a problem with Chinese papers since many Chinese scientists have names in common, without ORCID identifiers.

  5. I still don’t understand how articles such as this – which only show some weak correlation – get published at all, let alone in premiere journals. If you look long enough, I am sure you can correlate dementia rates in any population with preference of a blue shirt vs. a red shirt, or the won/loss records of Manchester United – but we all know that is meaningless. Logically, by what action would wearing a hearing aid cause or prevent dementia? Unless an article like this has some specifics about actions and causation I don’t think they should get published at all.

    1. It’s a fairly consistent association and there are some hypotheses about potential causal pathways:
      10.1016/j.neuron.2020.08.003
      10.3389/fnagi.2021.769405

  6. When I was interviewed for this piece, I was not aware of Dr. Mur and his sustained and admirable efforts to set the record straight.

    I am puzzled as to why the Lancet editors did not publish his invited submission along with their retraction notice. To have done so would have (a) helped set the record straight (important because their retraction notice was somewhat cryptic); and (b) given credit where credit was due (important in any case, but particularly so in the case of a junior researcher).

    As someone who works in this field, I am grateful to Dr. Mur and his colleagues for their scientific spirit and energy. They have made a real contribution.

  7. Over the years, both The Lancet and Livingston have consistently advocated a stance on hearing rehabilitation and dementia that appears more akin to personal opinion than objective analysis. Their approach has been notably non-conservative, relying on a limited number of articles, some of which are questionable, as exemplified by the referenced article whose conclusions have now become evident to all. The publication has, unfortunately, contributed to numerous instances of misinformation and misinterpretation by others.

    A case in point is their review on hearing, hearing aids, and dementia, where the authors hastily asserted that hearing aids could slow down dementia based on a handful of studies that lack reproducibility, failing to acknowledge the limitations inherent in these retrospective studies.

    In light of this, it comes as no surprise that Dr. Mur’s article was not published, as it diverges from their established narrative. Speculation may arise regarding potential funding ties between this publication and hearing aid companies, a factor that could explain the alignment with a particular viewpoint.

  8. “hearing aids and dementia after prodding”

    I get prodded a lot by the Frau Doktorin so this is something I should probably worry about.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.